相似文献
1
Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.
Gut. 1998 Apr;42(4):470-6. doi: 10.1136/gut.42.4.470.
2
Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
Gastroenterology. 1995 May;108(5):1434-44. doi: 10.1016/0016-5085(95)90692-4.
3
Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
Clin Exp Immunol. 1996 Jun;104(3):483-90. doi: 10.1046/j.1365-2249.1996.39750.x.
4
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Clin Exp Immunol. 1993 Oct;94(1):174-81. doi: 10.1111/j.1365-2249.1993.tb05997.x.
5
Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
Scand J Gastroenterol. 1997 Oct;32(10):1028-34. doi: 10.3109/00365529709011220.
6
Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
Gut. 1998 Feb;42(2):214-9. doi: 10.1136/gut.42.2.214.
7
Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Gut. 1997 Nov;41(5):651-7. doi: 10.1136/gut.41.5.651.
8
Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies.
Dig Dis Sci. 1997 Jul;42(7):1557-66. doi: 10.1023/a:1018895500721.
9
Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 1999 Mar;11(3):267-76. doi: 10.1097/00042737-199903000-00010.
10
Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Inflamm Bowel Dis. 2009 Mar;15(3):328-34. doi: 10.1002/ibd.20759.
引用本文的文献
1
Differential activation of monocytes and PMNs in orofacial granulomatosis patients induced by bacterial and non-bacterial stimuli.
Front Immunol. 2025 May 6;16:1522495. doi: 10.3389/fimmu.2025.1522495. eCollection 2025.
2
First Description of Simultaneous Sweet Syndrome and Tracheal Stenosis as Extraintestinal Manifestations in a Patient With Highly Active Ulcerative Colitis.
ACG Case Rep J. 2025 May 19;12(5):e01712. doi: 10.14309/crj.0000000000001712. eCollection 2025 May.
3
inhibits the TNF-α-induced increase in intestinal epithelial tight junction permeability via a TLR-2 and PI3K-dependent inhibition of NF-κB activation.
Front Immunol. 2024 Jul 16;15:1348010. doi: 10.3389/fimmu.2024.1348010. eCollection 2024.
4
Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
Front Immunol. 2023 Oct 26;14:1234535. doi: 10.3389/fimmu.2023.1234535. eCollection 2023.
5
expression in myeloid cells modulates the pathogenesis of dextran sulfate sodium (DSS)-induced colitis.
Front Immunol. 2023 May 22;14:1163987. doi: 10.3389/fimmu.2023.1163987. eCollection 2023.
6
Fruits of in human leukocytes and Caco-2 cell monolayer models-A question about their preventive role in lipopolysaccharide leakage and cytokine secretion in endotoxemia.
Front Pharmacol. 2022 Sep 30;13:981874. doi: 10.3389/fphar.2022.981874. eCollection 2022.
7
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Aug 4;16(7):1097-1109. doi: 10.1093/ecco-jcc/jjac003.
8
Aspartate Metabolism Facilitates IL-1β Production in Inflammatory Macrophages.
Front Immunol. 2021 Oct 21;12:753092. doi: 10.3389/fimmu.2021.753092. eCollection 2021.
9
Macrophage polarization in intestinal inflammation and gut homeostasis.
Inflamm Res. 2020 Dec;69(12):1163-1172. doi: 10.1007/s00011-020-01398-y. Epub 2020 Sep 4.
10
The relationship between preoperative T helper cytokines in the ileal mucosa and the pathogenesis of pouchitis.
BMC Gastroenterol. 2020 Aug 18;20(1):277. doi: 10.1186/s12876-020-01421-w.
本文引用的文献
1
Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.
Gastroenterology. 1997 Aug;113(2):383-9. doi: 10.1053/gast.1997.v113.pm9247454.
2
The NF-kappa B and I kappa B proteins: new discoveries and insights.
Annu Rev Immunol. 1996;14:649-83. doi: 10.1146/annurev.immunol.14.1.649.
3
Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein.
Gastroenterology. 1996 Mar;110(3):733-9. doi: 10.1053/gast.1996.v110.pm8608882.
4
The role of interleukin-1 in disease.
N Engl J Med. 1993 Jan 14;328(2):106-13. doi: 10.1056/NEJM199301143280207.
5
Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.
J Clin Pathol. 1993 Aug;46(8):757-60. doi: 10.1136/jcp.46.8.757.
6
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.
Gut. 1993 Sep;34(9):1203-6. doi: 10.1136/gut.34.9.1203.
7
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Clin Exp Immunol. 1993 Oct;94(1):174-81. doi: 10.1111/j.1365-2249.1993.tb05997.x.
8
Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites.
Gastroenterology. 1993 Jul;105(1):60-6. doi: 10.1016/0016-5085(93)90010-a.
9
PMN-elastase in assessment of patients with inflammatory bowel disease.
Dig Dis Sci. 1993 Sep;38(9):1638-44. doi: 10.1007/BF01303172.
10
Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.
J Exp Med. 1993 Dec 1;178(6):2207-11. doi: 10.1084/jem.178.6.2207.
Zotero 插件